chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cellulitis in arm; Dizzy head; sore; a few lymph nodes reacted; This is a spontaneous report from a contactable consumer. A 39-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unknown date in Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown if patient was pregnant. The patient received the first dose of BNT162B2 (lot number: EL0140) on 28Dec2020 for covid-19 immunization. On an unknown date in Jan2021, the patient experienced Dizzy head and sore. Then injection site swelling and was hot to the touch and a few lymph nodes reacted. Two days of 102+ fever, diagnosis of cellulitis in arm. Antibiotics received for cellulitis. Adverse event result in Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering. Information on the lot/batch number has been requested.
After 1st dose on 3/4/21, she developed "brain fog" which gradually became worse. After 2nd dose on 4/1, she started showing  many symptoms of "Rapidly progressive dementia". The only change in medication or change in her lifestyle was the Covid vaccine.
45-60 minutes post vaccination, patient experienced right eye twitching continuous for a few hours, then intermittent x 24 hrs; now resolved 12 hours post vaccination, patient experienced right ear/jaw numbness that lasted up to 36hrs 36 hrs post vaccination, the numbness is spreading to the right cheek no affect in muscle function, just numb pt seen at urgent care facility 12/23 @~0830 and prednisone initiated
Blood sugar level higher than normal (340); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)). The patient was treated with INSULIN ASPART (INSULINE ASPARTATE) ongoing since an unknown date for Blood sugar increased, at an unspecified dose and frequency. At the time of the report, BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Blood glucose: 340 (High) more than normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment for the event included injectable insulin.
Joint bone pain entire body still have it; hands, wrists, ankles and feet had shooting burning pains; can't function, type, cook, or anything; hands, wrists, ankles and feet had shooting burning pains; This is a spontaneous report from a contactable consumer (patient) received via the regulatory authority. A non-pregnant 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 17Mar2021 05:15 (Lot Number: Eng204) (at the age of 54 years old) as dose 1, single for COVID-19 immunisation (also reported as dose number 2 on 17Mar2021 at 17:15 Lot Number: En6204; for confirmation). The vaccine was administered in a Pharmacy or Drug Store. The patient's medical history included asthma, inflammatory bowel disease, and known allergies: penicillin and latex. Concomitant medications included ipratropium bromide;salbutamol sulfate (COMBIVENT), montelukast, and "ALBATROS" for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 16Apr2021 02:00, the patient experienced "Joint bone pain entire body still have it". The patient can't function, type, cook, or anything. The hands, wrists, ankles, and feet had shooting burning pains. The events resulted in a Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient received prednisone as a treatment. The patient has not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Sore throat 4 plus days Body aches White cirle on left arm with shiny look
with the combination of COVID, I never got my 2nd/booster shot; Shingrix shortage, I never got my 2nd/booster shot; This case was reported by a consumer via call center representative and described the occurrence of social problem in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in December 2020.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem and product supply issue. On an unknown date, the outcome of the social problem and product supply issue were unknown.    Additional Information: GSK Receipt Date: 16-JUN-2022 Reporter's comment: The patient stated that he/she received 1st Shingrix dose in December of 2020. The reporter said that with the combination of COVID and a Shingrix shortage in his/her area, the patient never got the 2nd /booster shot. The patient asked would he/she had to start over with the first shot. The administer at his/her local said this, and based on what he/she had read, that did not sound correct. Additional Supportive Information: The patient could not get the 2nd dose of Shingrix vaccine due to Shingrix shortage in his/her area, which led to product supply issue.
THIS VACCINE WAS ADMISTERED TO THE PATIENT AND IT WAS EXPIRED THE EXPRIRATION DATE IS 11/09/18.
I had a lot of soreness a few days after the shot; the soreness has never gone away and seems to be worse the last few days. It is painful when I raise my arm. I have not sought any medical attention yet.
Pt presented with a local reaction on 13Feb15. She stated it got bigger since her vaccine. The shot was given SQ instead of IM.
2. On, 1/13/21, employee received vaccine. Employee c/o dizziness 15 minutes after receiving vaccine. She stated it started 5 minutes prior to that but didn't report it then. Checked employee's site and slight redness noted; no warmth; patient temperature 98.7, HR 96; denies SOB/difficult breathing; patient states she is sleepy and feels like her breathing is slowing down-RR WNL; laid employees head back to alleviate dizziness; waited with employee for another 20 minutes with no new symptoms developing, other than her feeling flush; employee desired to be evaluated in ER; was taken via w/c to personal vehicle and driven to ER; Employee had lab drawn and was discharged with diagnosis of weakness, fatigue, dizziness and giddiness.
Information has been received from a healthcare worker concerning a 17 year old female patient with no known drug reactions/allergies and medical history who on 15-OCT-2008 was vaccinated intramuscularly with the first dose 0.5 ml dose of GARDASIL (Lot #660618/0572X), and on 22-DEC-2008 with the second dose of GARDASIL (Lot #661044/0548X). There was no concomitant medication. On 29-DEC-2008 at home the patient experienced syncope and possible seizure. The patient was evaluated at a local emergency room and a CT scan of the brain and Electrocardiogram were normal. Since then, the patient had experienced persistent dizziness, headaches, and nausea. The patient was examined in the office and was prescribed PREVACID. An Electroencephalogram was normal. The stool was positive for occult blood so the patient was referred to an unspecified gastroenterologist. An abdominal ultrasound and endoscopy had been scheduled. The patient sought medical attention. At the time of reporting the patient was not recovered. Upon internal review seizures were considered to be an other important medical event. Additional information has been requested.
Pt recvd vax 3MAR93 & 4MAR woke up w/t103 R was sluggish & wouldn't eat; was admitted to hosp 4MAR @ noc w/t105; mom states MD felt had an infection in blood probably from immun;
This case was reported by a consumer via call center representative and described the occurrence of constipation in a 75-year-old female patient who received SHINGRIX for prophylaxis. On 17th January 2019, the patient received SHINGRIX (intramuscular) .5 ml. In January 2019, 2 days after receiving SHINGRIX, the patient experienced constipation. On an unknown date, the outcome of the constipation was recovered/resolved. It was unknown if the reporter considered the constipation to be related to SHINGRIX. Additional details were provided as follows: The patient had constipation 2 to 3 days after the injection. It took at least 10 days for the constipation to clear up. The reporter provided the consent to follow up.
Transfer child was admitted on 8/6/2022. Child was seen for his health assessment with PCP in our care on 8/8/2022. System shows historical vaccine information for child in question.Child received incorrect immunization dose on 8/16/2022. System was updated with transfer historical information by medical coordinator on 8/15. Assigned Transfer of file Medical Coordinator.NP was made aware of the scenario and states no recommendations at this time due to more than 24 hours of incident.  No reports s/s of reaction.
we talk to the radiologist about getting the Pfizer booster and he said, yes you should definitely get it and get it asap so, we got it Thursday afternoon; we talk to the radiologist about getting the Pfizer booster and he said, yes you should definitely get it and get it asap so, we got it Thursday afternoon; He is shaking like tremoring; Little fatigue; Fever; temperature and its only 99.3; Freezing; Shivering; I just don't feel alright; This is a spontaneous report from a contactable consumer. A male patient (reporter's husband) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 3 via an unspecified route of administration on an unspecified date as dose 3, single for covid-19 immunisation.  Medical history included Immunocompromised, Cancer, Metastases to brain. The patient also underwent radiation treatment on Wednesday afternoon and (voice not clear) he has metastases to his brain (medical condition) and they have talked to the radiologist about getting the Pfizer booster and he recommended to definitely get it. The patient's concomitant medications were not reported.  Historical vaccine included BNT162B2  as dose 1 and dose 2 on unspecified date for COVID-19 immunization . On an unspecified date, the patient experienced "we talk to the radiologist about getting the pfizer booster and he said, yes you should definitely get it and get it asap so, we got it thursday afternoon", he is shaking like tremoring, little fatigue, fever; temperature and its only 99.3, freezing, shivering, i just don't feel alright.  The patient underwent lab tests and procedures which included pyrexia: 99.3 fahrenheit on  Fever; temperature and its only 99.3. It was reported that the patient got the vaccine Thursday afternoon and he was little fatigue obviously from the radiation and now not sure if its also from the booster and the biggest symptoms were he was shaking like tremoring like he had the high fever and freezing and his temperature was  99.3.The reporter asked if it was a normal reaction. Reporter asked since it was Saturday, would there be somebody there to address them. Reporter was informed that the Pfizer Medical Information Department closed on Saturday and Sunday and was advised to contact health care provider at that time.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow-up (27Sep2021) This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made.   Follow-up attempts completed. No further information is expected.
Small red rash at first. Overnight, rash grew to the size of the palm of my hand. Red, raised, itchy.
Syncopal episode (Syncope). A man, born on 4/22/23, was vaccinated for the 4th time with RabAvert, batch no, unknown, on 10/2/06. He has subsequently been hospitalised for a syncopal episode attributed to his past history of atrial fibrillation. Medical plan included ablation therapy for treatment of arrhythmia and pacemaker placement. Pt still in hospital at time of call 4/4/06. Caller did not feel that the hospitalisation could be attributed to the RabAvert vaccination.
just had usual side effects and mild symptoms for 48 hours.; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (just had usual side effects and mild symptoms for 48 hours.) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION COMPLICATION (just had usual side effects and mild symptoms for 48 hours.). On 22-Feb-2021, VACCINATION COMPLICATION (just had usual side effects and mild symptoms for 48 hours.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-355923 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Oct-2021: Follow-up information received contains no new information
Patient started to exhibit severe hip pain. She said it was sensitive to the touch and she could barely move. After further discussion she said she does have history of arthritis and the weather got significantly cooler today, and also had precipitation that she said sometimes worsens her arthritis that she hadn't thought about previously.
Patient came in with a severely swollen left arm especially in the bicep and triceps areas with severe redness. Her Doctor advised her to take benedryl and apply ice to the area.
Patient developed bruise later that day on R deltoid area. Next day patient went to swimming pool for exercise and bruise was "baseball-sized" and was confused and went home without exercising. Patient stated that she slept that day and part of the next day. Patient didn't seek treatment and bruise has resolved.
Roughly 1 week after the 2nd dose, experienced mild vasoocclusive crisis in right forearm and hip that, over the course of several days, evolved into a severe crisis that was nonresponsive to oral opiods and required visit to ER for IV opiods.
Slight arm soreness about 12 hours after injection, with severe rigors shortly thereafter. Fever to 101.8 and uncontrollable shaking/chills, and moderate to severe headache. Rigors lasted about 6 hours, headache persists.
Janssen COVID-19 Vaccine EUA Severe joint and muscle pain all over the body starting at 7:30 pm. Progressively worsening overnight. Overall weakness, cold shivers, severe palpitations with 136 heart rate in resting position. Initially decreased temperature and then increased temperature to 101. Tramadol for pain and diazepan for sleep taken at night. Felt better by the next day afternoon.
Case number PHEH2013US001308, is an initial spontaneous report received from a nurse on 12 Jan 2013. This report refers to an unspecified age and gender patient. The patient medical history and concomitant medication was not reported. The patient received only Men C, Y, W-135 liquid conjugate component of MENVEO vaccine (batch number: not reported), intramuscularly without being reconstituted with Men A component on an unspecified date. No adverse reaction reported following this administration error.
Received call from pt on 11/14/13. She reports receiving flu vaccine on 10/31/13 around 2 PM. That evening around 5 PM states her ears started ringing. Around 8 PM that evening, she experienced sharp spasms in both shoulders which traveled to middle back, to butt, to both thighs and to both  knees. Then felt "charley horse" type cramps in both forearms. She awakened during the night that same night with the cramping spasms again as described earlier with the worst pain seeming to be in the knees. The next day 11/1/13, states her knees "felt like they were gelled up" and noticed swelling in both knees, which has continued to get a little worse each day since then. On Sunday, 11/3/13, she noticed blurriness in the "lower 1/3" of her right eye which persists through today. On 11/8/13, she went to clinic and saw nurse practitioner. She suggested steroids, but pt said she does not tolerate steroids well so they suggested ibuprofen and Benadryl. The swelling and pain in her knees has continued to get worse, making it difficult for pt to walk. She saw a rheumatologist today and he aspirated 22 cc of fluid from the left knee and 23 cc of fluid from the right knee which he is sending to be tested. She has a follow-up appt in 2 weeks unless symptoms become worse or she feels she needs to see him sooner than that. The muscle spasms have been very intermittent since that first night with the most recent being 3 days ago in the left forearm. Knee swelling and pain has increased as described above, and the blurriness in the right eye has remained unchanged since it started.
Redness and raised area L deltoid injection site No warmth or swelling. No pain noted
Nausea began 3-4 days after injection.I've had nausea for more than a week now.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Apr2021 at 18:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to black olives. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (MANUFACTURER UNKNOWN). for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 14:00, the patient experienced nausea which began 3-4 days after injection, and the patient had nausea for more than a week now. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination the patient not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event nausea was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
After the vaccine about an hour, I start getting severe abdominal cramps. The pain was very bad that I started to faint, I even fainted in my kitchen. I also had diarrhea for about an hour. And throughout the day I still had bad cramps, during the night I had a bad fever and chilis. The next day I still had the abdominal cramps and diarrhea, and this is when I called the doctor.
Felt achy, fever 102.4 urinated more oftren then normal (urine was checked at physical the day of vaccine-which was normal). Also had headache.
Within in minutes I had a strong metallic taste in mouth and order in nasal passages. Heart racing and lightheaded. I was given water, observed, and told to call for a ride. Felt better in 15 - 20 min. was tired rest of the day.
Fever; Chills; Swelling; GI symptoms; This case was reported by a physician via call center representative and described the occurrence of fever in an unspecified number adult patients who received Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, chills, injection site swelling and gastrointestinal symptom nos. On an unknown date, the outcome of the fever, chills, injection site swelling and gastrointestinal symptom nos were unknown.   It was unknown if the reporter considered the fever, chills, injection site swelling and gastrointestinal symptom nos to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not applicable for this report. The physician reported side effects for approximately 30 percent of his patients seen over several clinics. After receiving Shingrix, the patient complain of fever, chills swelling at injection site and gastrointestinal symptoms. The reporter consented to follow up. The doctor stated that he believes it is 30 percent of 30 patient administered the vaccine which were approximately 9 patients. No specific data was given at the time of call.
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Sep2022 at 13:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 29 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19; Negative, notes: 6 days after negative rapid test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Known allergies: None; Other medical history: None. Other medication in 2weeks product is Umcka (Nature's Way), start date 06Oct2022, stop date 09Oct2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201252936 Same patient, different product and event;
Arm swelling, throat swelling, hypotension then hypertension,  ongoing dizzy spells
Patient developed COVID-19 symptoms and tested positive on 3/21/2021 after getting vaccinated on 3/20/2021.  Patient has a history of COVID - he tested positive on November 16 of 2020.   Patient's records also list "Acute respiratory failure with hypoxia (*) likely secondary to COPD exacerbation secondary to COVID-19 vaccine reaction" - this was listed as a Problem in his chart on 3/21/2021. - This is his listed prinicpal problem at admission to the hospital on 3/21/2021.